Radar · Life Sciences Tech in Cambridge
Best Life Sciences Tech Companies in Cambridge, United States
The 98 best Life Sciences Tech companies in Cambridge, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: XtalPi.
By Rohit KhannaTrends & Stories
98companies tracked
$4.6Bdisclosed funding
1unicorns
53have raised
FLIAR INTELLIGENCE · LIFE SCIENCES TECH × CAMBRIDGE
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
89%cloud-native stacks
2025funding peak (by rounds)
8unicorns
2018median founding year
549kcombined LinkedIn audience
53%of audience held by top 3
4companies hiring publicly (12 mo)
Ranked: Best Life Sciences Tech companies in Cambridge
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | XtalPi 🦄 AI-based drug research and development company 64Funding top 18%AI top 26%Talent top 28%Patents top 31% All 13 signals ▾Fundingtop 18% AItop 26% Talenttop 28% Patentstop 31% Moattop 31% Innovationtop 34% Producttop 35% Newstop 38% Techtop 39% Growthtop 47% Globaltop 50% Marketbottom 43% Fin. healthbottom 32% Funding: Raised $785M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) AI: Classified as an AI company · Product described with: ai-based, machine learning rank vs industry peers · Fliar Intelligence Index 64/100 | $785M | 9 mo ago | Public | 27 | — | WordPressMySQLPHP+28 | 14 patents Small-molecule STING agonists and PI3Kβ inhibitors for immuno‑oncology therapeutics | 1 partnership |
| 2 | Nimbus Therapeutics Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases | $637M | 33 mo ago | Series F | 81 81 → 99 (+22%) · sector median +26% | Jeb Keiper CEO | WordPressApple iCloud MailMySQL+14 | — | — |
| 3 | Relay Therapeutics Developer of drug discovery platform and study protein motion | $520M | 29 mo ago | Public | 245 245 → 218 (-11%) · sector median +26% | David Shaw Co-Founder | WordPressDrupalApple iCloud Mail+23 | 234 patents Small-molecule FGFR and PI3Kα kinase inhibitors for oncology applications | — |
| 4 | In Silico AI-enabled bioinformatics platform for drug discovery and biomarker development 82Funding top 15%Product top 19%AI top 20%News top 26% All 12 signals ▾Fundingtop 15% Producttop 19% AItop 20% Newstop 26% Partnerstop 26% Talenttop 28% Moattop 31% Innovationtop 35% Growthtop 35% Markettop 43% Techtop 46% Globalbottom 39% Funding: Raised $400M across 11 rounds · 11 rounds over 12 yrs (0.9/yr) Product: 3 distinct product lines · Company stage: Public rank vs industry peers · Fliar Intelligence Index 82/100 | $400M | 17 mo ago | Public | 300 | Alex Zhavoronkov Co-Founder & Co-CEO | SentryMUIReact+10 | — | — |
| 5 | Cellarity AI-powered drug design and development platform | $294M | 44 mo ago | Series C | 117 117 → 72 (-38%) · sector median +26% | — | — | 26 patents AI-driven drug discovery and cellular diagnostic platforms using heterocyclic modulators | — |
| 6 | METiS Therapeutics Provider of an AI-assisted platform for drug discovery and development | $252M | 50 mo ago | Series B | 33 | Wenshou Wang Co-Founder | WixSentryBootstrap+9 | — | 1 partnership |
| 7 | Harbinger Health AI-based cancer detection tool for providers 55Funding top 18%News top 36%Moat top 42%AI top 45% All 8 signals ▾Fundingtop 18% Newstop 36% Moattop 42% AItop 45% Talenttop 49% Techbottom 48% Marketbottom 43% Globalbottom 38% Funding: Raised $140M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) News: 2 BI events in 12 mo (of 13 tracked, 3 types) · Top themes: Leadership rank vs industry peers · Fliar Intelligence Index 55/100 | $140M | 2 mo ago | Series B | 60 | Stephen Hahn CEO | WordPressApple iCloud MailMySQL+23 | — | 2 launchs |
| 8 | Diagonal Therapeutics Developer of antibody therapeutics for the treatment of rare diseases 40Funding top 19%Moat top 42%Talent bottom 49%Market bottom 40% All 5 signals ▾Fundingtop 19% Moattop 42% Talentbottom 49% Marketbottom 40% Globalbottom 38% Funding: Raised $128M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) Moat: Editorial + unicorn rating 5/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 40/100 | $128M | 5 mo ago | Series B | — | Alexey Lugovskoy CEO | — | — | — |
| 9 | Warp Drive Bio Discovery platform to find drugs for undruggable cancers | $125M | 173 mo ago | Acqui-Hired | 50 | — | — | — | — |
| 10 | Zageno Marketplace and life science research community for biotech research kits | $121M | 36 mo ago | Series C | 51 51 → 127 (+149%) · sector median +26% | Florian Wegener Co-Founder & CEO | HubSpot CMS HubApple iCloud MailGoogle Workspace+21 | — | 1 launch |
| 11 | Seven Bridges Genomics Biomedical data analysis company accelerating healthcare research with software and analytics | $113M | 61 mo ago | Acquired | 112 | William Moss CEO | WordPressMySQLPHP+30 | 243 patents Graph-based genomic variant detection and analysis, including tumor mutational burden and viral sequencing | — |
| 12 | Stipple Bio Provider of a platform that utilizes epitope-level resolution to unlock cellular profiling and target… 21Funding top 20%Talent top 38%Global bottom 48%Tech bottom 25% All 5 signals ▾Fundingtop 20% Talenttop 38% Globalbottom 48% Techbottom 25% Marketbottom 19% Funding: Raised $109M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 21/100 | $109M | 2 mo ago | Series A | 2 | Aaron Ring Co-Founder | WordPressMySQLPHP+11 | — | 1 partnership |
| 13 | TriNetX Provider of clinical trial management software for researchers and professionals | $102M | 87 mo ago | Acquired | 95 | Gadi Lachman Founder & CEO | Master SliderWordPressSentry+44 | 15 patents Standardized clinical data querying and patient cohort identification for trial recruitment. | — |
| 14 | Atavistik Developer of allosteric therapeutics for precision oncology and rare diseases 50Funding top 19%Talent top 28%Moat top 31%Market bottom 42% All 6 signals ▾Fundingtop 19% Talenttop 28% Moattop 31% Marketbottom 42% Globalbottom 36% Newsbottom 33% Funding: Raised $100M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 50/100 | $100M | 3 mo ago | Series B | 33 | Ralph DeBerardinis Co-Founder | — | — | — |
| 15 | Vesalius Therapeutics Provider of genomics platform to treat various diseases | $75M | 51 mo ago | Series C | 33 33 → 32 (-3%) · sector median +26% | Douglas Cole Co-Founder | — | — | 1 job opening |
| 16 | Transition Bio Developer of a technology platform for the analysis of biomolecular condensate | $69M | 20 mo ago | Series B | 9 | David Weitz Co-Founder | WordPressMySQLPHP+13 | — | — |
| 17 | nference Provider of an AI platform for clinical data analysis and insights | $63M | 44 mo ago | Series C | 165 165 → 316 (+92%) · sector median +26% | Murali Aravamudan Co-Founder & CEO | PrismicNode.jsMUI+19 | 126 patents Patents concentrated in computing, sensing & instrumentation | — |
| 18 | Cambridge Soft Discovery, collaboration, and knowledge enterprise solutions | $57M | 199 mo ago | Acquired | 51 | — | — | — | — |
| 19 | Metaphore Provider of machine language and computational platform for drug discovery 42Funding top 23%Talent top 28%Moat top 42%AI top 45% All 7 signals ▾Fundingtop 23% Talenttop 28% Moattop 42% AItop 45% Globalbottom 36% Techbottom 35% Marketbottom 31% Funding: Raised $50.0M across 1 rounds · 1 rounds over 3 yrs (0.3/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 42/100 | $50M | 2 mo ago | Series C | 30 | Noubar Afeyan Co-Founder | WebflowMicrosoft 365jQuery+4 | — | — |
| 20 | Montai Health Montai Therapeutics is a pioneering pharmaceutical company focused on developing innovative, predictably… | $50M | 42 mo ago | Series A | 46 46 → 61 (+33%) · sector median +26% | Hok Tam Co-Founder | Tailwind CSSOpenSSLGSAP+7 | — | — |
| 21 | Oncimmune Immunodiagnostics company developing biomarker platforms for cancer and immune diseases | $49M | 20 mo ago | Acquired | 62 62 → 35 (-44%) · sector median +26% | Jamie Heywood Managing Director | WordPressMySQLPHP+21 | 4 patents Immunoassay development and calibration technologies for diagnostic testing | — |
| 22 | Elemental Machines Provider of data driven drug discovery and development platform for various industries | $47M | 43 mo ago | Series B | 84 | Sridhar Iyengar Co-Founder & Chief Strategy and Technology Officer | WordPress Block EditorWordPressMySQL+18 | 72 patents Patents concentrated in electrical & electronics | — |
| 23 | Ovation Provider of a cloud-based laboratory information and data management platform for researchers and clinicians | $34M | 68 mo ago | Series B | 35 35 → 45 (+29%) · sector median +26% | Winston Brasor Co-Founder/GM | — | 45 patents Advanced firearm fire‑control and trigger mechanisms for AK‑type weapons | — |
| 24 | Labviva Digital marketplace for life science products | $31M | 17 mo ago | Series B | 8 | Nicholas Rioux Co-Founder & CTO | — | — | 1 launch · 4 partnerships |
| 25 | 1910 Genetics Developer of small molecule therapeutics to treat pain and aging-related diseases | $30M | 19 mo ago | Series A | 18 | Jen Nwankwo Founder & CEO | — | — | — |
| 26 | Cure Forward Online clinical trial enrollment platform and DNA mapping from partnered labs | $28M | 109 mo ago | Deadpooled | 30 | — | — | — | — |
| 27 | Knome Genomic interpretation systems and services accelerating translational genomics and precision medicine | $25M | 149 mo ago | Acquired | 18 | — | — | 6 patents Scoring genomic variants and personal genome data storage/analysis platforms. | — |
| 28 | Xellar Developer of an AI-based computational platform for drug discovery | $24M | 23 mo ago | Series A | 12 | Xin Xie Co-Founder | — | 6 patents Patents concentrated in computing, sensing & instrumentation | — |
| 29 | Virtify Provider of content and compliance management software | $24M | 158 mo ago | Deadpooled | 23 | — | — | — | — |
| 30 | Ketryx Provider of AI-native compliance software for regulated medical applications development 45Funding top 30%Tech top 40%AI top 45%Growth top 48% All 9 signals ▾Fundingtop 30% Techtop 40% AItop 45% Growthtop 48% Talentbottom 49% Moatbottom 48% Marketbottom 32% Newsbottom 31% Globalbottom 29% Funding: Raised $18.0M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) Tech: 36 technologies across 5/8 capability areas · Cloud: Amazon Web Services, Cloudflare rank vs industry peers · Fliar Intelligence Index 45/100 | $18M | 11 mo ago | Series B | 19 | Erez Kaminski CEO | WebflowSentryWistia+32 | — | — |
| 31 | LabCentral Provider of shared laboratory space and facility for biotech startups | $18M | 80 mo ago | Series B | 55 | Johannes Fruehauf Founder | Craft CMSPHPYii+22 | — | 1 internship · 1 partnership · 2 awards |
| 32 | NextCode Health Providing analytics platform for genome analysis. | $15M | 151 mo ago | Acquired | 13 | — | — | — | — |
| 33 | ExpressionEdits Provider of protein expression platform development services | $13M | 24 mo ago | Seed | 9 | Allan Bradley Co-Founder | Framer SitesVimeoReact+9 | — | — |
| 34 | Totient Developer of a drug discovery platform for cancer and autoimmune disease by using artificial intelligence | $10M | 65 mo ago | Acqui-Hired | 26 | Deniz Kural Co-Founder & CEO | — | 10 patents Therapeutic antibodies and recombinant protein production platforms for cancer and disease targets | — |
| 35 | Qrativ AI based drug purposing platform to identify treatments for rare diseases | $8M | 107 mo ago | Series A | 1 | Murali Aravamudan Co-Founder & CEO | — | — | — |
| 36 | Leadart Biotechnologies Provider of drug target discovery platform and probe library | $6M | 41 mo ago | Seed | 60 | Yufeng Zhao Co-Founder | — | — | — |
| 37 | Vistapath AI and cloud-based pathology processing platform for diagnosis | $5M | 35 mo ago | Seed | 6 | Ben Burley Co-Founder | — | — | — |
| 38 | Via Scientific Provider of multi-omics and analytics platform for scientists and computational biologists | $5M | 29 mo ago | Seed | — | James Crowley Co-Founder & CEO | WebflowApple iCloud MailGoogle Workspace+12 | — | — |
| 39 | Curii Developer of open-source platform for managing large biomedical datasets | $4M | 105 mo ago | Funding Raised | — | Tom Clegg Co-Founder | — | — | — |
| 40 | QSimulate Laboratory focused on developing of quantitative simulation tools to help in quantum molecular 32Growth top 35%Talent top 38%Funding top 41%Moat top 48% All 7 signals ▾Growthtop 35% Talenttop 38% Fundingtop 41% Moattop 48% Techbottom 36% Globalbottom 36% Marketbottom 24% Growth: Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 32/100 | $4M | 7 mo ago | Seed | 14 14 → 21 (+50%) · sector median +26% | Toru Shiozaki Co-Founder & CEO | UbuntuYouTubeBootstrap+6 | — | 1 job opening |
| 41 | Sproxil Mobile technology to combat counterfeit products | $3M | 112 mo ago | Series A | 54 | — | WordPress Block EditorElementorWordPress+28 | 11 patents Anti-counterfeit product verification using serialized identifiers and tamper‑evident packaging | 1 partnership |
| 42 | Trove Health Platform providing access to medical records for patients and providers | $3M | 31 mo ago | Series A | 19 | Matt Ross Co-Founder & CEO | — | — | — |
| 43 | Genometry Developer of technologies for low-cost gene expression profiling | $3M | 165 mo ago | Deadpooled | 8 | Arvind Subramanian Co-Founder | — | — | — |
| 44 | Applied BioMath Systems biology and pharmacology modeling services to aid drug discovery and development | $2M | 34 mo ago | Acquired | 61 | Josh Apgar Co-founder and CSO | — | — | — |
| 45 | Legit AI-based platform for creating invention disclosure forms | $2M | 106 mo ago | Acquired | 12 | Anthony Bucci Co-Founder & CSO | — | 3 patents Social recommendation algorithms and weighted search ranking for online content personalization | — |
| 46 | Gesund AI Provider of clinical-grade AI solutions for regulatory compliance | $2M | 33 mo ago | Seed | 20 | — | Node.jsFirebaseAnt Design+11 | — | — |
| 47 | Cytel Provider of data analysis and statistical solutions for the life sciences industry | $2M | 103 mo ago | Acquired | 509 | Cyrus Mehta Co-Founder & President | WordPressApple iCloud MailMicrosoft 365+31 | 43 patents Clinical trial design and analytics platform integrating systematic literature review | — |
| 48 | Standard Molecular Provider of genomic information system for diagnostic and therapeutic applications | $1M | 98 mo ago | Deadpooled | — | David Artz Co-Founder | — | — | — |
| 49 | MNM Bioscience AI-assisted platform for cancer drug discovery and development | $800K | 50 mo ago | Deadpooled | 36 | Pawel Zawadzki Co-Founder & CEO | — | — | — |
| 50 | PatLynk Provider of AI-powered clinical trial matching to connect patients with relevant medical innovations and… | $100K | 23 mo ago | Seed | — | Elise Khaleghy Co-founder & CEO | TurbopackNode.jsRadix UI+14 | — | — |
Top 12 Life Sciences Tech companies in Cambridge
#1
Series B · Cambridge, Massachusetts · founded 2008 · 60 employees$140Mraised▾
Series B · Cambridge, Massachusetts · founded 2008 · 60 employees
AI-based cancer detection tool for providers. The company has developed a blood test detection tool that enables professionals to analyze and detect early cancers.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Funding
top 18%News
top 36%Moat
top 42%AI
top 45%Talent
top 49%Tech
bottom 48%Funding: Raised $140M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series B (Apr 2026)
News: 2 BI events in 12 mo (of 13 tracked, 3 types) · Top themes: Leadership
Moat: Editorial + unicorn rating 4/10 · Soonicorn · 10 curated direct competitors tracked
Audience (LinkedIn): 8k LinkedIn followers
Activity (LinkedIn): 2 product launches announced in 12 mo
Funding rounds
- Apr 2026Series B$100M
- Sep 2023Series B$140M
- 2021Series A$50M
Founders & team
Investors
Flagship Pioneering, Pictet Group, Partners Investment, Venture Catalysts, M&G, Camillus LifeSciences
Tech stack
Apple Icloud MailCloudflareCloudflare Bot ManagementCore-JsGoogle AnalyticsGoogle Font Api
#2
XtalPi 🦄Public · Cambridge, Massachusetts · founded 2014 · 27 employees$784.8Mraised▾
XtalPi 🦄
Public · Cambridge, Massachusetts · founded 2014 · 27 employees
XtalPi has developed a proprietary technology FACES(Fast Accurate Crystalline Engineering System), which is a cloud-based computing system to predict the crystal structure which will identify polymorphs of the compound. The company's algorithms are integrated with the Amazon Web Service (AWS) high-performance computing (HPC) resources in the cloud. The team claims to have a strong background in quantum physics and machine learning. It provides services to pharmaceutical companies at various stages of drug development. The company has deployed its technology to develop an Intelligent Digital Drug Discovery and Development (ID4) platform to improve the efficiency, accuracy, and success rate of drug discovery.
Fliar Intelligence Index™ 64how this company ranks against its industry peers
Funding
top 18%AI
top 26%Talent
top 28%Patents
top 31%Moat
top 31%Innovation
top 34%Funding: Raised $785M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) · Last round Post IPO (Sep 2025)
AI: Classified as an AI company · Product described with: ai-based, machine learning
Talent: Analyst team rating 4/5
Audience (LinkedIn): 18k LinkedIn followers — 3.2% of this cohort's audience
Activity (LinkedIn): 1 partnerships (incl. OpenEye, Cadence Molecular Sciences) announced in 12 mo
Funding rounds
- Sep 2025Post IPO$268M
- Feb 2025Post IPO$268.4M
- Aug 2021Series D$400M
- Sep 2020Series C$318.8M
Investors
Tencent, Frees Fund, Zhen Fund, Renren, SoftBank Vision Fund, People's Insurance Company of China
Tech stack
Animate.CssBootstrapCdnjsCloudflareCloudflare Bot ManagementCore-Js
#3
Series A · Cambridge, Massachusetts · founded 2021 · 2 employees$109.5Mraised▾
Series A · Cambridge, Massachusetts · founded 2021 · 2 employees
Provider of a platform that utilizes epitope-level resolution to unlock cellular profiling and target discovery. The platform technology enables single-cell profiling and target identification for ddrug discovery and development of cancer immunotherapy and others.
Fliar Intelligence Index™ 21how this company ranks against its industry peers
Funding
top 20%Talent
top 38%Global
bottom 48%Tech
bottom 25%Market
bottom 19%Funding: Raised $109M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Series A (Mar 2026)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Global: Investors from 1 country beyond United States
Audience (LinkedIn): 4k LinkedIn followers
Activity (LinkedIn): 1 partnerships (incl. Lonza) announced in 12 mo
Funding rounds
- Mar 2026Series A$100M
- Dec 2024Series A$9.5M
Founders & team
Investors
RA Capital Management, Andreessen Horowitz, Nextech Invest, Emerson Collective, Google Ventures, GordonMD Global Investments
Tech stack
AstraCore-JsElementorGoogle Font ApiGoogle Hosted LibrariesJquery
#4
Series B · Cambridge, Massachusetts · founded 2021 · 33 employees$100Mraised▾
Series B · Cambridge, Massachusetts · founded 2021 · 33 employees
Developer of allosteric therapeutics for precision oncology and rare diseases. The company integrated with proprietary drug discovery platform that enables to unlock novel allosteric binding pockets and rapidly advance structural insights into small molecule therapeutics designt to unlock cryptic allosteric sites across a broad range of target classes.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Funding
top 19%Talent
top 28%Moat
top 31%Market
bottom 42%Global
bottom 36%News
bottom 33%Funding: Raised $100M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) · Last round Series B (Mar 2026)
Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 8/10 · Soonicorn · 10 curated direct competitors tracked
Audience (LinkedIn): 4k LinkedIn followers
Funding rounds
- Mar 2026Series B$40M
- Dec 2025Series B$120M
- Dec 2023Series A$40M
- Aug 2021Series A$60M
Founders & team
Investors
The Column Group, Lux Capital, Nextech Invest, Regeneron Ventures, RA Capital Management
#5
Series B · Cambridge, Massachusetts · founded 2022$128Mraised▾
Series B · Cambridge, Massachusetts · founded 2022
Developer of antibody therapeutics for the treatment of rare diseases. The company's DIAGONAL platform combines proprietary computational and experimental techniques to develop agonist antibody therapies for hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension.
Fliar Intelligence Index™ 40how this company ranks against its industry peers
Funding
top 19%Moat
top 42%Talent
bottom 49%Market
bottom 40%Global
bottom 38%Funding: Raised $128M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Series B (Jan 2026)
Moat: Editorial + unicorn rating 5/10 · Soonicorn · 10 curated direct competitors tracked
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Audience (LinkedIn): 6k LinkedIn followers
Funding rounds
- Jan 2026Series B$125M
- Apr 2024Series A$128M
Founders & team
Investors
VF Partners, Atlas Venture, CHECKPOINT, Frazier Life Sciences, Lightspeed Venture Partners, RA Capital Management
#6
Series C · Cambridge, Massachusetts · founded 2021 · 30 employees$50Mraised▾
Series C · Cambridge, Massachusetts · founded 2021 · 30 employees
Provider of machine language and computational platform for drug discovery. The company uses biomimicry and machine learning to unleash the transformational medicinal potential of functional molecular mimics. The MIMiC platform, developed by the company is a computationally driven bioplatform for developing novel therapies in which function, specificity, and selectivity may be optimized.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Funding
top 23%Talent
top 28%Moat
top 42%AI
top 45%Global
bottom 36%Tech
bottom 35%Funding: Raised $50.0M across 1 rounds · 1 rounds over 3 yrs (0.3/yr) · Last round Series C (Apr 2026)
Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 4/10 · Soonicorn · 9 curated direct competitors tracked
Audience (LinkedIn): 5k LinkedIn followers
Funding rounds
- Apr 2026Series C—
- May 2023Series C$50M
Founders & team
Investors
Flagship Pioneering, TOHO HOLDINGS
Tech stack
CloudflareHstsHttp/3JqueryMicrosoft 365Webflow
#7
Public · Cambridge, Massachusetts · founded 2014 · 300 employees$399.8Mraised▾
Public · Cambridge, Massachusetts · founded 2014 · 300 employees
AI-enabled bioinformatics platform for drug discovery and biomarker development. The company provides solutions and services such as custom drug discovery engines, biomarker discovery, and aging research tools to academia, pharmaceutical, and cosmetics companies. Also, it has developed a product PHARMA.AI which includes modules for drug discovery such as PandaOmics, Chemistry42, and InClinico.
Fliar Intelligence Index™ 82how this company ranks against its industry peers
Funding
top 15%Product
top 19%AI
top 20%News
top 26%Partners
top 26%Talent
top 28%Funding: Raised $400M across 11 rounds · 11 rounds over 12 yrs (0.9/yr) · Last round Series E (Jan 2025)
Product: 3 distinct product lines · Company stage: Public
AI: Classified as an AI company
Audience (LinkedIn): 88k LinkedIn followers — 16.0% of this cohort's audience
Funding rounds
- Jan 2025Series E$110M
- Aug 2022Series D$35M
- Jun 2022Series D$60M
- Jun 2021Series C$255M
Founders & team
Investors
Prosperity7 Ventures, Qiming Venture Partners, BHR, Warburg Pincus, Bold Capital Partners, Pavilion Capital Partners
Tech stack
Amazon SesAmazon Web ServicesDdos-GuardEmotionGoogle AnalyticsGoogle Font Api
#8
Series B · Cambridge, Massachusetts · founded 2021 · 19 employees$18Mraised▾
Series B · Cambridge, Massachusetts · founded 2021 · 19 employees
Provider of AI-native compliance software for regulated medical applications development. The software facilitates compliance with FDA, EU MDR, and ISO regulations. It offers application lifecycle management, requirements management, risk management, and documentation automation. The platform integrates with development tools, providing traceability and enforcement of quality management systems.
Fliar Intelligence Index™ 45how this company ranks against its industry peers
Funding
top 30%Tech
top 40%AI
top 45%Growth
top 48%Talent
bottom 49%Moat
bottom 48%Funding: Raised $18.0M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) · Last round Series B (Jul 2025)
Tech: 36 technologies across 5/8 capability areas · Cloud: Amazon Web Services, Cloudflare · Observability: Sentry
AI: Product described with: ai-native
Audience (LinkedIn): 19k LinkedIn followers — 3.4% of this cohort's audience
Funding rounds
- Jul 2025Series B$39M
- Nov 2023Series A$14M
- Nov 2021Seed$2M
Founders & team
Investors
Lightspeed Venture Partners, Ubiquity Ventures, E14 Fund, Transformation Capital, 53 Stations
Tech stack
CdnjsCloudflareCloudflare Bot ManagementContentsquareConvertCore-Js
#9
Seed · Cambridge, Massachusetts · founded 2018 · 14 employees$4Mraised▾
Seed · Cambridge, Massachusetts · founded 2018 · 14 employees
Laboratory focused on developing of quantitative simulation tools to help in quantum molecular
Fliar Intelligence Index™ 32how this company ranks against its industry peers
Growth
top 35%Talent
top 38%Funding
top 41%Moat
top 48%Tech
bottom 36%Global
bottom 36%Growth: Fresh capital in last 24 mo
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Funding: Raised $4.0M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) · Last round Seed (Nov 2025)
Audience (LinkedIn): 3k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Business Development Representative
Funding rounds
- Nov 2025Seed—
- Apr 2025Grant (prize money)$272.4K
- Mar 2025Grant (prize money)$273.4K
- Nov 2023Seed$2.5M
Founders & team
Investors
2xN, UTokyo Innovation Platform, Kyoto University Innovation Capital, Embark Ventures, HHS, Abies Ventures
Tech stack
BootstrapGoogle AnalyticsGoogle WorkspaceHstsNginxPwa
#10
Acquired · Cambridge, Massachusetts · founded 2006 · 62 employees$49.4Mraised▾
Acquired · Cambridge, Massachusetts · founded 2006 · 62 employees
Immunodiagnostics company developing biomarker platforms for cancer and immune diseases. It leverages its proprietary ImmunoINSIGHTS platform, which uses large-scale autoantibody profiling and immune system analysis to generate actionable insights for drug development and patient stratification. Its technology enables pharmaceutical and biotechnology partners to identify disease-specific immune signatures, supporting earlier diagnosis, improved therapy development, and more precise treatment selection.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers
Funding rounds
- Oct 2024Post IPO$2.9M
- Dec 2022Post IPO—
- Mar 2021Post IPO$12.3M
- Oct 2020Grant (prize money)—
Founders & team
Investors
Genostics, Ukri, IPF Partners, HHS, Nottingham Technology Ventures, Kansas Bioscience Authority
Tech stack
Amazon SesAmazon Web ServicesAosBootstrapContact Form 7Core-Js
#11
Series B · Cambridge, Massachusetts · founded 2017 · 8 employees$30.8Mraised▾
Series B · Cambridge, Massachusetts · founded 2017 · 8 employees
Digital marketplace for life science products. The company has developed an AI-powered digital marketplace that connects researchers with suppliers of reagents, chemicals, and instrumentation in the life sciences industry. It integrates with procurement systems
LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Activity: 1 product launches · 4 partnerships (incl. Conquer Scientific LLC) announced in 12 mo
Funding rounds
- Jan 2025Series B$25M
- Mar 2023Series A$20M
- Jun 2021Seed$8M
- 2020Seed$2M
Founders & team
Investors
Biospring Partners, Senator Investment Group, Glasswing Ventures, B Capital, 53 Stations, SeedFolio
Tech stack
WixYoutubeReactGoogle CloudPolyfillLodash
#12
Series B · Cambridge, Massachusetts · founded 2020 · 9 employees$69.3Mraised▾
Series B · Cambridge, Massachusetts · founded 2020 · 9 employees
Developer of a technology platform for the analysis of biomolecular condensate. The company's proprietary platform includes Condensomics which combines microfluidic approaches and protein biophysics that can be used for drug discovery and diagnostics.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers
Activity: 1 partnerships (incl. Voyager Therapeutics, Inc.) announced in 12 mo
Funding rounds
- Oct 2024Series B$13.3M
- Dec 2023Series A$6M
- Jun 2022Series A$50M
- Sep 2020Seed—
Founders & team
Investors
Northpond Ventures, Taiho Ventures, Bristol-Myers Squibb, Magnetic Ventures, Lifeforce Capital
Tech stack
Apache Http ServerBluehostBootstrapContact Form 7Google AnalyticsJquery
Funding & investor landscape
$4.6Btotal disclosed funding
52companies funded
176disclosed rounds
3rounds last 90 days
Most active investors
Notable founders
Stephen Hahn
CEO · Harbinger Health
Aaron Ring
Co-Founder · Stipple Bio
Aashish Manglik
Co-Founder · Stipple Bio
Ralph DeBerardinis
Co-Founder · Atavistik
Jared Rutter
Co-Founder · Atavistik
Alexey Lugovskoy
CEO · Diagonal Therapeutics
Noubar Afeyan
Co-Founder · Metaphore
Lovisa Afzelius
Co-Founder & CEO · Metaphore
Alex Zhavoronkov
Co-Founder & Co-CEO · In Silico
Stephanie Williams
Co-Founder · In Silico
Erez Kaminski
CEO · Ketryx
Toru Shiozaki
Co-Founder & CEO · QSimulate
Prism market signals · United States · country-scoped Prism corpus, 2,593,976 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN CAMBRIDGE · Health & Bio
How research on Biotechnology in Cambridge is moving
A read on the academic research around Biotechnology in Cambridge — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 62 papers.
University of Cambridge and NHS Trust lead Cambridge's biotech research, focusing optimistically on plant molecular biology, epigenetics, and stem cells, with breakthroughs dominating recent output.
62 papers · stance +0.58 · 46% breakthrough · 14% concern
top institutions
- University of Cambridge54
- Cambridge School4
- Cambridge University Hospitals NHS Foundation Trust4
- Cancer Research UK Cambridge Center3
- Cambridge Life Sciences1
leading researchers
Facundo Romani · Ho‐Ming Chen · Jeanne Salje · Kanu Patel · V.G. MELNIKOV · A.K. SADANOV
prism intelligence · tone & topics
92% positive · 5% critical tone
Medical ResearchHealthPharmaceuticalsAgricultureBiologyGenetics
▲
Breakthroughs27 · 44%
▲ 33%→47% share
▲1.4× share momentum0 median citations74% since 2021mostly empirical
Mitochondrion and DNA methylation research newly emerging — each claiming 3 papers in Cambridge biotech.
rising sub-themes (early→recent)
- Chromatin1→3
Newly emergingMitochondrion 0→3 · DNA methylation 0→3
Landmark A MicroRNA Superfamily Regulates Nucleotide Binding Site–Leucine-Rich Repeats and Other mRNAs · 745 cites
◆
Advancements24 · 39%
▼ 42%→37% share
▼0.9× share momentum0 median citations71% since 2021mostly empirical
Antibody research rising to 3 papers as Advancements field-share cools from 42% to 37%.
rising sub-themes (early→recent)
- Antibody3
- Fermentation2
- Transcription (linguistics)2
- Gene2
- Methylation2
Landmark Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity · 1,150 cites
▼
Concerns8 · 13%
▼ 17%→12% share
▼0.7× share momentum1 median citations62% since 2021mostly empirical
Concerns field-share shrinking 17% to 12% despite cell adhesion research intensifying from 1 paper.
rising sub-themes (early→recent)
- Cell adhesion1
- Cell adhesion molecule1
- Follicular dendritic cells1
- Endocytosis1
- Neural cell adhesion molecule1
Landmark Life-Cycle Assessment of Potential Algal Biodiesel Production in the United Kingdom: A Comparison of Raceways and Air-Li · 556 cites
Common questions
How many Life Sciences Tech companies are there in Cambridge, United States?
Radar tracks 98 indexable Life Sciences Tech companies headquartered in Cambridge, United States that meet our profile-completeness bar.
What is the total funding raised by Life Sciences Tech companies in Cambridge, United States?
The Life Sciences Tech companies in Cambridge, United States on this list have raised a combined $4.6B in disclosed equity funding across 52 funded companies.
Which is the highest-funded Life Sciences Tech company in Cambridge, United States?
XtalPi is the highest-funded Life Sciences Tech company in Cambridge, United States, with $784.8M in disclosed equity funding.
How many Life Sciences Tech companies in Cambridge, United States are funded?
52 of the 98 Life Sciences Tech companies in Cambridge, United States on this list have disclosed at least one equity funding round.
How many Life Sciences Tech unicorns are there in Cambridge, United States?
1 Life Sciences Tech company in Cambridge, United States on this list is valued at $1B or more.
Who are the top investors in Cambridge, United States Life Sciences Tech companies?
The most active investors in Cambridge, United States Life Sciences Tech companies on this list include HHS, Flagship Pioneering, RA Capital Management, Yael Capital, BVF Partners.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.